Published in Toxicon on August 15, 2013
Accelerated intoxication of GABAergic synapses by botulinum neurotoxin A disinhibits stem cell-derived neuron networks prior to network silencing. Front Cell Neurosci (2015) 0.80
Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets. Pharmacol Rev (2017) 0.75
Mutations of optineurin in amyotrophic lateral sclerosis. Nature (2010) 4.54
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
Characterization of hyperintense plaque with noncontrast T(1)-weighted cardiac magnetic resonance coronary plaque imaging: comparison with multislice computed tomography and intravascular ultrasound. JACC Cardiovasc Imaging (2009) 1.76
Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol (2005) 1.70
Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am J Hum Genet (2007) 1.62
Subthreshold low-frequency repetitive transcranial magnetic stimulation over the premotor cortex modulates writer's cramp. Brain (2004) 1.59
Reduction of KCC2 expression and GABAA receptor-mediated excitation after in vivo axonal injury. J Neurosci (2002) 1.58
Defects in the striatal neuropeptide Y system in X-linked dystonia-parkinsonism. Brain (2013) 1.53
Bilateral pallidal deep brain stimulation in primary Meige syndrome. Parkinsonism Relat Disord (2010) 1.51
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses. J Exp Med (2007) 1.47
Sera from patients with multifocal motor neuropathy disrupt the blood-nerve barrier. J Neurol Neurosurg Psychiatry (2013) 1.45
Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater (2010) 1.45
Amyotrophic lateral sclerosis with IgM antibody against gangliosides GM2 and GD2. Intern Med (2003) 1.41
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature (2011) 1.41
Characterization of the neurotoxin produced by isolates associated with avian botulism. Avian Dis (2005) 1.39
Functional changes in piriform cortex pyramidal neurons in the chronic methamphetamine-treated rat. Gen Physiol Biophys (2014) 1.38
Increased variability of axonal excitability in amyotrophic lateral sclerosis. Clin Neurophysiol (2013) 1.38
Binding of Clostridium botulinum type C and D neurotoxins to ganglioside and phospholipid. Novel insights into the receptor for clostridial neurotoxins. J Biol Chem (2005) 1.37
Properties of corynephage attachment site and molecular epidemiology of Corynebacterium ulcerans isolated from humans and animals in Japan. Jpn J Infect Dis (2008) 1.35
The anatomical basis of dystonia: current view using neuroimaging. Mov Disord (2013) 1.27
Altered emotional behavioral responses in mice lacking brain-type fatty acid-binding protein gene. Eur J Neurosci (2006) 1.26
LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease. Mov Disord (2009) 1.22
Genetic characterization of Clostridium botulinum associated with type B infant botulism in Japan. J Clin Microbiol (2009) 1.21
Voltage-gated potassium channel complex antibodies in Creutzfeldt-Jakob disease. J Neurol (2012) 1.17
GABAA receptor phospho-dependent modulation is regulated by phospholipase C-related inactive protein type 1, a novel protein phosphatase 1 anchoring protein. J Neurosci (2004) 1.17
Sequence of the gene for Clostridium botulinum type B neurotoxin associated with infant botulism, expression of the C-terminal half of heavy chain and its binding activity. Biochim Biophys Acta (2003) 1.14
Characterization of the D/C mosaic neurotoxin produced by Clostridium botulinum associated with bovine botulism in Japan. Vet Microbiol (2009) 1.12
Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A (2008) 1.09
Role of the PLC-related, catalytically inactive protein p130 in GABA(A) receptor function. EMBO J (2002) 1.08
Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block. Brain (2002) 1.07
alpha 2-Adrenoceptor-mediated presynaptic modulation of GABAergic transmission in mechanically dissociated rat ventrolateral preoptic neurons. J Neurophysiol (2003) 1.06
Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress-induced apoptosis. J Biol Chem (2004) 1.06
Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.05
Nerve excitability testing and its clinical application to neuromuscular diseases. Clin Neurophysiol (2006) 1.04
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis. J Neurol Sci (2013) 1.04
Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol (2012) 1.03
TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol (2003) 1.02
The TRK-fused gene is mutated in hereditary motor and sensory neuropathy with proximal dominant involvement. Am J Hum Genet (2012) 1.02
Transsynaptic inhibition of spinal transmission by A2 botulinum toxin. J Physiol (2012) 1.01
Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis. J Neurol Sci (2009) 1.01
Cytokine-induced enhancement of calcium-dependent glutamate release from astrocytes mediated by nitric oxide. Neurosci Lett (2007) 1.00
Increased frequency of interleukin-1beta-511T allele in patients with temporal lobe epilepsy, hippocampal sclerosis, and prolonged febrile convulsion. Epilepsia (2003) 0.98
Characterization of novel bovine papillomavirus type 12 (BPV-12) causing epithelial papilloma. Arch Virol (2011) 0.97
Differential distributions of the Ca2+ -dependent activator protein for secretion family proteins (CAPS2 and CAPS1) in the mouse brain. J Comp Neurol (2006) 0.97
Identification of the receptor-binding sites in the carboxyl-terminal half of the heavy chain of botulinum neurotoxin types C and D. Microb Pathog (2008) 0.96
Molecular evidence of new variant Brucella in North Pacific common minke whales. Microbes Infect (2004) 0.95
Biochemical and molecular characterization of minor serogroups of Shiga toxin-producing Escherichia coli isolated from humans in Osaka prefecture. J Vet Med Sci (2007) 0.95
Nerve excitability properties in Charcot-Marie-Tooth disease type 1A. Brain (2003) 0.95
A novel neurotoxoid vaccine prevents mucosal botulism. J Immunol (2005) 0.95
Two Japanese Corynebacterium ulcerans isolates from the same hospital: ribotype, toxigenicity and serum antitoxin titre. J Med Microbiol (2010) 0.95
Comparison of effects of botulinum toxin subtype A1 and A2 using twitch tension assay and rat grip strength test. Toxicon (2010) 0.94
Activation of presynaptic glycine receptors facilitates glycine release from presynaptic terminals synapsing onto rat spinal sacral dorsal commissural nucleus neurons. J Physiol (2003) 0.94
Bilateral deep brain stimulation of the globus pallidus internus in tardive dystonia. Mov Disord (2008) 0.94
Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis (Edinb) (2007) 0.94
Adenosine A1 receptor-mediated presynaptic inhibition of GABAergic transmission in immature rat hippocampal CA1 neurons. J Neurophysiol (2003) 0.94
Clinicopathologic study on an ALS family with a heterozygous E478G optineurin mutation. Acta Neuropathol (2011) 0.93
Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy. Stroke (2013) 0.92
The Na(+)/H(+) exchanger is a major pH regulator in GABAergic presynaptic nerve terminals synapsing onto rat CA3 pyramidal neurons. J Neurochem (2006) 0.92
Type A1 but not type A2 botulinum toxin decreases the grip strength of the contralateral foreleg through axonal transport from the toxin-treated foreleg of rats. J Pharmacol Sci (2011) 0.92
Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson's disease. Mov Disord (2009) 0.91
Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. J Immunol (2006) 0.91
Safety and efficacy of intravenous ultra-high dose methylcobalamin treatment for peripheral neuropathy: a phase I/II open label clinical trial. Intern Med (2014) 0.91
Stress control and human nutrition. J Med Invest (2004) 0.91
Functional roles of presynaptic GABA(A) receptors on glycinergic nerve terminals in the rat spinal cord. J Physiol (2002) 0.91
Alpha 1-adrenoceptor-activated cation currents in neurones acutely isolated from rat cardiac parasympathetic ganglia. J Physiol (2003) 0.90
Threshold electrotonus in chronic inflammatory demyelinating polyneuropathy: correlation with clinical profiles. Muscle Nerve (2004) 0.90
The effects of volatile anesthetics on synaptic and extrasynaptic GABA-induced neurotransmission. Brain Res Bull (2012) 0.90
Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy. Neurosci Lett (2005) 0.90
Increasing and persistent DWI changes in a patient with hereditary diffuse leukoencephalopathy with spheroids. J Neurol Sci (2013) 0.89
Epidemiology of primary dystonias in Japan: comparison with Western countries. Mov Disord (2003) 0.89
Effects of ethanol on GABA(A) receptors in GABAergic and glutamatergic presynaptic nerve terminals. J Pharmacol Exp Ther (2012) 0.88
Pathological and serological evidence of Brucella-infection in baleen whales (Mysticeti) in the western North Pacific. Comp Immunol Microbiol Infect Dis (2003) 0.88
Circadian rhythm in intracellular Cl(-) activity of acutely dissociated neurons of suprachiasmatic nucleus. Am J Physiol Cell Physiol (2002) 0.88
The El Escorial criteria: strengths and weaknesses. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.88